| Abstrakt: |
The article from Kosin University School of Medicine discusses the current status of chemotherapy in colorectal cancer treatment, emphasizing the challenges faced by patients with metastatic colorectal cancer. The research highlights the use of adjuvant chemotherapy post-surgery and palliative chemotherapy for metastatic cases, as well as recent updates in treatment guidelines such as the integration of immunotherapy and the role of circulating tumor DNA (ctDNA) in personalized medicine. The aim is to enhance treatment efficacy, improve patient survival, and reduce recurrence rates in colorectal cancer management. [Extracted from the article] |
